World Mental Health Day was observed for the first time on 10 October 1992. The day, officially commemorated every year on October 10th, aims to raise awareness in the global community about the critical mental health agendas – with a unifying voice through collaboration with various partners – to take action and to create lasting change. It was started as an annual activity of the World Federation for Mental Health by the then Deputy Secretary-General Richard Hunter. In 1994, at the suggestion of then Secretary-General Eugene Brody, a theme for the Day was used for the first time.
For World Food Day 2022, RELX's Global Head of Corporate Responsibility, Dr. Márcia Balisciano, speaks to Dr. Rickey Yada.
This Personal View supports SDG 3 by explaining how plastic waste can facilitate the proliferation and propogation of infectious diseases, including arthropod-borne and water-borne diseases, among its other negative effects on the environment
This Article supports SDG 3 by assessing the safety and efficacy profile of abacavir used in first, second, or subsequent lines of treatment for infants, children, and adolescents living with HIV to inform 2021 WHO paediatric ART recommendations.
Elsevier,
Present Knowledge in Food Safety: A Risk-Based Approach through the Food Chain, Volume 1, 1 January 2022
This chapter aligns with Goal 3: Good health and well-being by providing an overview of the food safety hazards related to microplastic pollution in food and agricultural systems.
This review article is about free radical generation during viral infection, including HIV, with a special emphasis on detection methods.
This review explores the role of transmembrane neuropilin-1 (NRP-1) in pregnancy, preeclampsia (PE), human immunodeficiency virus type 1 (HIV-1) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Since these conditions are assessed independently, this review attempts to predict their comorbid clinical manifestations.
This study uses targeted plasma proteomics to show the upregulation of inflammation in people living with HIV.
Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant disorder characterized by progressive muscle weakness. Adenine nucleotide translocator 1 (ANT1), the only 4q35 gene involved in mitochondrial function, is strongly expressed in FSHD skeletal muscle biopsies. However, its role in FSHD is unclear. In this study, we evaluated ANT1 overexpression effects in primary myoblasts from healthy controls and during Xenopus laevis organogenesis. We also compared ANT1 overexpression effects with the phenotype of FSHD muscle cells and biopsies.
This Article supports SDG 3 and 5 by highlighting a need for greater involvement of in-country authors on research examining a wider range of gendered COVID-19 impacts, as well as increased representation of diverse topics and publications related to COVID-19 and women's well-being focused on lower income countries.
